Fusion gene information | Fusion gene name: NALCN-GRM5 |
Fusion gene ID: hg259232tg2915 | | Hgene | Tgene | Gene symbol | NALCN | GRM5 | Gene ID | 259232 | 2915 | Gene name | sodium leak channel, non-selective | glutamate metabotropic receptor 5 |
Synonyms | CLIFAHDD|CanIon|IHPRF|IHPRF1|INNFD|VGCNL1|bA430M15.1 | GPRC1E|MGLUR5|PPP1R86|mGlu5 |
Cytomap | ('NALCN')('GRM5') 13q32.3-q33.1 | 11q14.2-q14.3 |
Type of gene | protein-coding | protein-coding |
Description | sodium leak channel non-selective proteinfour repeat voltage-gated ion channelvoltage gated channel like 1 | metabotropic glutamate receptor 5glutamate receptor, metabotropic 5protein phosphatase 1, regulatory subunit 86 |
Modification date | 20200313 | 20200329 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000251127, ENST00000376196, ENST00000376200, ENST00000470333,
| |
Fusion gene scores | * DoF score | 4 X 4 X 1=16 | 7 X 5 X 4=140 |
# samples | 4 | 7 |
** MAII score | log2(4/16*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/140*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: NALCN [Title/Abstract] AND GRM5 [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | NALCN(101960103)-GRM5(88279241), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NALCN | C3809454 | HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1 | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | NALCN | C4225398 | CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | NALCN | C0220662 | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 1 | ORPHANET |
Hgene | NALCN | C0265224 | Freeman-Sheldon syndrome | 1 | ORPHANET |
Hgene | NALCN | C1834523 | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 1 | ORPHANET |
Hgene | NALCN | C1852085 | Digitotalar Dysmorphism | 1 | ORPHANET |
Tgene | | C0036341 | Schizophrenia | 3 | PSYGENET |
Tgene | | C0041696 | Unipolar Depression | 3 | PSYGENET |
Tgene | | C1269683 | Major Depressive Disorder | 3 | PSYGENET |
Tgene | | C0038220 | Status Epilepticus | 2 | CTD_human |
Tgene | | C0041671 | Attention Deficit Disorder | 2 | CTD_human |
Tgene | | C0270823 | Petit mal status | 2 | CTD_human |
Tgene | | C0311335 | Grand Mal Status Epilepticus | 2 | CTD_human |
Tgene | | C0393734 | Complex Partial Status Epilepticus | 2 | CTD_human |
Tgene | | C0751522 | Status Epilepticus, Subclinical | 2 | CTD_human |
Tgene | | C0751523 | Non-Convulsive Status Epilepticus | 2 | CTD_human |
Tgene | | C0751524 | Simple Partial Status Epilepticus | 2 | CTD_human |
Tgene | | C1263846 | Attention deficit hyperactivity disorder | 2 | CTD_human |
Tgene | | C1321905 | Minimal Brain Dysfunction | 2 | CTD_human |
Tgene | | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | | C0009171 | Cocaine Abuse | 1 | CTD_human |
Tgene | | C0011882 | Diabetic Neuropathies | 1 | CTD_human |
Tgene | | C0013146 | Drug abuse | 1 | CTD_human |
Tgene | | C0013170 | Drug habituation | 1 | CTD_human |
Tgene | | C0013222 | Drug Use Disorders | 1 | CTD_human |
Tgene | | C0014556 | Epilepsy, Temporal Lobe | 1 | CTD_human |
Tgene | | C0014558 | Uncinate Epilepsy | 1 | CTD_human |
Tgene | | C0027796 | Neuralgia | 1 | CTD_human |
Tgene | | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Tgene | | C0038580 | Substance Dependence | 1 | CTD_human |
Tgene | | C0038586 | Substance Use Disorders | 1 | CTD_human |
Tgene | | C0038870 | Neuralgia, Supraorbital | 1 | CTD_human |
Tgene | | C0042656 | Neuralgia, Vidian | 1 | CTD_human |
Tgene | | C0234247 | Neuralgia, Atypical | 1 | CTD_human |
Tgene | | C0234249 | Neuralgia, Stump | 1 | CTD_human |
Tgene | | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
Tgene | | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Tgene | | C0271673 | Symmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Tgene | | C0271674 | Asymmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Tgene | | C0271678 | Diabetic Mononeuropathy | 1 | CTD_human |
Tgene | | C0271680 | Diabetic Polyneuropathies | 1 | CTD_human |
Tgene | | C0271685 | Diabetic Amyotrophy | 1 | CTD_human |
Tgene | | C0271686 | Diabetic Autonomic Neuropathy | 1 | CTD_human |
Tgene | | C0393672 | Epilepsy, Benign Psychomotor, Childhood | 1 | CTD_human |
Tgene | | C0393682 | Epilepsy, Lateral Temporal | 1 | CTD_human |
Tgene | | C0393835 | Diabetic Asymmetric Polyneuropathy | 1 | CTD_human |
Tgene | | C0423711 | Neuralgia, Perineal | 1 | CTD_human |
Tgene | | C0423712 | Neuralgia, Iliohypogastric Nerve | 1 | CTD_human |
Tgene | | C0600427 | Cocaine Dependence | 1 | CTD_human |
Tgene | | C0740858 | Substance abuse problem | 1 | CTD_human |
Tgene | | C0751074 | Diabetic Neuralgia | 1 | CTD_human |
Tgene | | C0751371 | Neuralgia, Ilioinguinal | 1 | CTD_human |
Tgene | | C0751372 | Nerve Pain | 1 | CTD_human |
Tgene | | C0751373 | Paroxysmal Nerve Pain | 1 | CTD_human |
Tgene | | C1510472 | Drug Dependence | 1 | CTD_human |
Tgene | | C4316881 | Prescription Drug Abuse | 1 | CTD_human |